Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2025-12-26 @ 4:26 AM
Study NCT ID:
NCT06265727
Status:
RECRUITING
Last Update Posted:
2025-11-04
First Post:
2024-02-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
Sponsor:
Corbus Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2027-01-16
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01-27
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-08
First Submit QC Date:
None
Study First Post Date:
2024-02-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-03
Last Update Post Date:
2025-11-04
Last Update Post Date Type:
ESTIMATED